Fatty Liver Completed Phase 2 Trials for 3-(cyclohexylamino)propanesulfonic acid (DB02219)

Also known as: Liver fatty / Infiltration fatty liver / Fatty liver metamorphosis / Liver fatty metamorphosis / Metamorphosis fatty liver / Liver fatty degeneration / Degeneration fatty liver / Liver fatty infiltration / Fatty liver infiltration / Steatosis of liver (disorder) / Liver fatty change / Steatosis hepatic / Hepatic steatosis / Steatohepatitis (disorder) / Steatohepatitis

IndicationStatusPhase
DBCOND0028942 (Fatty Liver)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01147523
Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver DiseaseTreatment